FDA Charges Ranbaxy with Falsifying Data at India Plant

15:14 PM | March 9, 2009 | Deepti Ramesh

The U.S. FDA has charged Ranbaxy Laboratories (Gurgaon, India) with falsifying data and test results in approved and pending drug applications at the company’s Paonta Sahib, India facility. The agency...